COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 852: Articles 8511-8520  | Next

Sustained patient use and improved outcomes with digital transformation of a COPD service: RECEIVER trial and DYNAMIC-SCOT COVID-19 scale-up response.
Taylor, A., Cushing, A., Dow, M., Anderson, J., McDowell, G., Manthe, M., Padmanabhan, S., Burns, S., McGineess, P., Lowe, D. J., Carlin, C. M.
10.1101/2022.04.04.22273427 — Posted: 2022-04-05
Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: A cohort analysis of 2.7M people.
Green, M. A., Hungerford, D. J., Hughes, D. M., Garcia-Finana, M., Turtle, L., Cheyne, C., Ashton, M., Leeming, G., Semple, M. G., Singleton, A., Buchan, I.
10.1101/2022.04.05.22273169 — Posted: 2022-04-05
Automated method to extract and purify RNA from wastewater enables more sensitive detection of SARS-CoV-2 markers in community sewersheds
West, N. W., Vasquez, A. A., Bahmani, A., Khan, M., Hartrick, J., Turner, C. L., Shuster, W., Ram, J. L.
10.1101/2022.04.03.22273370 — Posted: 2022-04-05
Modeling behavior change and underreporting in the early phase of COVID-19 pandemic in Metro Manila, Philippines
Mendoza, V. M. P., Mendoza, R., Ko, Y., Lee, J., Jung, E.
10.1101/2022.03.29.22273148 — Posted: 2022-04-05
Cannabis potential effects to prevent or attenuate SARS-COV2 contagion
Herrera-Gomez, P., Echeveri-Catano, L. F., Ruiz Colorado, Y. A., Giraldo Galeano, S., Velez van Meerbeke, A.
10.1101/2022.03.31.22273181 — Posted: 2022-04-05
EARLY OUTPATIENT TREATMENT OF COVID-19: A RETROSPECTIVE ANALYSIS OF 392 CASES IN ITALY
Cosentino, M., Vernocchi, V., Martini, S., Marino, F., Allasino, B., Balzola, M., Burigana, F., Dallari, A., Pagano, C. S. F., Palma, A., Rango, M.
10.1101/2022.04.04.22273356 — Posted: 2022-04-05
The network of SARS-CoV-2-cancer molecular interactions and pathways
Erola, P., Martin, R., Gaunt, T. R.
10.1101/2022.04.04.487020 — Posted: 2022-04-05
Time series analysis of SARS-CoV-2 genomes and correlations among highly prevalent mutations
Periwal, N., Rathod, S. B., Sarma, S., Johar, G., Jain, A., Barnwal, R. P., Srivastava, K. R., Kaur, B., Arora, P., Sood, V.
10.1101/2022.04.05.487114 — Posted: 2022-04-05
Combination of Baricitinib plus Remdesivir and Dexamethasone improves time to recovery and mortality among hospitalized patients with severe COVID-19 infection
Perez Gutierrez, V. A., Shah, V., Afzal, A., Khalid, A., Yangco, A., Ocrospoma, S., Cemalovic, N., Pillai, A., Kasubhai, M., Dimitrov, V., Menon, V.
10.1101/2022.04.04.22273425 — Posted: 2022-04-05
Determinants of mortality among COVID-19 patients with diabetes mellitus in Addis Ababa, Ethiopia, 2022: An unmatched case-control study
Sibhat, M. M., Getnet, M. T., Chane, W. Z., Gebeyehu, K. T., Habtamu, A. S., Mezgebu, T. A., Asmare, H. B., Ambaw, M. M., Getahun, E. M.
10.1101/2022.04.04.22273344 — Posted: 2022-04-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).